Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metabolic Effects of LCZ696 vs Amlodipine in Obese Hypertensive Subjects
NCT01631864Phase 2Completed
- Sponsor
- Novartis
- Start
- Oct 2012
- Primary completion
- Jul 2013
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of sacubitril + valsartan in hypertension (HTN), sponsored by Novartis. Started Oct 2012; status: completed.
02
Drugs
sacubitril + valsartan
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT01631864.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01631864.